The Influence of Neuropharmaca on the Content of Choline in Brain

Authors

  • Bogdan Bošković
  • Olga Darvaš
  • Pavel Štern

DOI:

https://doi.org/10.5644/Radovi.76

Abstract

The influence of 33 drugs, from various pharmacological groups, on the content of choline in the mouse brain have been tested. The method we used gives the total amount of choline including one from acetylcholine. Results have showed that there is no correlation between the pharmacologic effect and the content of choline, when the drugs from similar or antagonistic pharmacologic groups were used. The influence of these compounds on the activity of cholinesterase or cholinacetylase was not in relation with the content of choline. Some drugs from the same pharmacologic group probable act differently the choline diffusion from central nervous system.

References

Koelle G. B.: Handbuch der experimentellen Pharmakologie, Enganzungsaband 15, Springer Verlag, Berlin—Gdfctingen—Heidelber, 1963.

Kates M.: Lipolytic enzymas, 165, iz Konrad Bloch "Lipide Metabolism" John Wiley & Sons, Ine. New York — London, 1960.

Matthews E. K.: Brit. J. Pharmacol, 21, 244 (1963).

Chargaff E., Lovine C.: Journ. of Biol. Cham, 192, 465 (1951).

Košak R.: Aota Pharm. Jug. 4, 119 (1959).

Sourkes T.: Arch. Biochem. Biophys. 51, 444 (1954).

Berger F. M., Bradley W.: Brit. J. Pharmacol. 1, 265 (1946).

Berger F. M.: J. Pharm, Exper. Therap. 112, 413 (1954).

Berger F. M., Douglas J. F., Kletzkin M., Ludwig J., Mar­golin S.: J. Pharm. Exper. Therap. 134, 356 (1961).

Berger F. M., Kletzkin M., Ludwig B. J., Margolin S., Powell L. S.: J. Pharm. Exper. Therap. 127, 66 (1959).

Stern P., Bošković B.: De Medicina Tuenda, u štampi.

Schueler F. W., Pfeiffer C. C., Smythies J. R.: "International Review of Netur.obiology" vel 2, Acađemic Press, Naw York — London, 77 (1960).

Herken H., Neubert D.: Arch. Exper. Pharmacol. 219, 223 (1953).

Feldberg W. J.: Physiol. (Lond.) 107, 327 (1948).

Spectoir S.: Annals of the New York Acađemic of Sciences 107, 856 (1963).

Longo V. G.: J. Pharmacol. Exper. Therap. 132, 240 (1961).

Brooks V. B., Curitis D. R., Eccles J. C.: Nature 175, 120 (1955).

Bašagiić E., Bošković B., Stern P.: Arch. int. Pharmaoodyn 137, 49 (1962).

Stern P., Gašparović I.: First Internat. Pharmacol. Meeting 8, 149 (1961).

Holmstedt B., Lundgreen G., Sundwall A.: Life Sciences 10, 731 (1963).

Balotiin N. M., Coon J. M.: Arch. int. Pharmaccdyn, 123, 395 (1960).

Bošković B., Fuks Ž., Stern P.: Naučno društvo NRBiH, Radovi, knjiga XVII, 83 (1963).

Eicholtz F., Feuerste'in D.: Arch. imit. Pharmacodyn 139, 423 (1962).

Perry W. L. M.: Brit. Med. Bul. 13, 220 (1957).

Birks R.: Cand. J. Biochcm. 39, 787 (1961).

Režek A.: Privatno sacpštenje.

Sehaumann W.: Bniit. J. Pharmacol. 15. 432 (1960).

Feldberg W.: Arch. Expcr. Pharmacol. 212, 64 (1950).

Smiith R. D., Bevan W.: Proc. Soc. Exper. Elol. Med. 96, 382 (1957).

Pfeiffer C. C., Jeney E. H., Gallagher W., Smath R. P., Bevan W. J r., Killam K. F., Killam E. K„ Blackome W.: Science, 126, 10 (1957).

Stern P.: Naiturwissenschaften 51, 90 (1964).

Carlsson A., Lindpvist M.: Acta Physiol. Scand. 54, 87 (1964).

Published

18.06.1964

Issue

Section

Works

How to Cite

The Influence of Neuropharmaca on the Content of Choline in Brain. (1964). Acta Medica Academica, 10, 22-28. https://doi.org/10.5644/Radovi.76

Most read articles by the same author(s)

1 2 > >>